Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
about
Texosome-based drug delivery system for cancer therapy: from past to presentNanoparticulate adjuvants and delivery systems for allergen immunotherapySelf-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic NanoparticlesCell delivery of therapeutic nanoparticlesConvergence of nanotechnology and cancer prevention: are we there yet?Improvement of different vaccine delivery systems for cancer therapy.A trifunctional dextran-based nanovaccine targets and activates murine dendritic cells, and induces potent cellular and humoral immune responses in vivo.Lipid nanocapsule as vaccine carriers for his-tagged proteins: evaluation of antigen-specific immune responses to HIV I His-Gag p41 and systemic inflammatory responsesDevelopment of individualized anti-metastasis strategies by engineering nanomedicinesMaterials from peptide assembly: towards the treatment of cancer and transmittable diseaseMultivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody.Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 VectorsEnhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticlesConfiguration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor ImmunityNanocarrier-based immunotherapy in cancer management and research.Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles.Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapyFabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity.In vivo biodistribution of nanoparticles.The effects of engineered nanoparticles on pulmonary immune homeostasis.Nanocarriers in therapy of infectious and inflammatory diseases.Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.Recent advances in developing vaccines against Toxoplasma gondii: an update.Dendritic cell-based immunotherapy: a basic review and recent advances.Application of nanostructured drug delivery systems in immunotherapy of cancer: a review.Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy.Nanomedicine approaches to improve cancer immunotherapy.A tetravalent dengue nanoparticle stimulates antibody production in miceRationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy.Application of nanoparticles on diagnosis and therapy in gliomas.Moving towards improved vaccines for Toxoplasma gondii.Enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergen.Encapsulation of Hydrophilic and Hydrophobic Peptides into Hollow Mesoporous Silica Nanoparticles for Enhancement of Antitumor Immune Response.A nano particle vector comprised of poly lactic-co-glycolic acid and monophosphoryl lipid A and recombinant Mycobacterium avium subsp paratuberculosis peptides stimulate a pro-immune profile in bovine macrophages.Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes.Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment.Vaccination with trifunctional nanoparticles that address CD8+ dendritic cells inhibits growth of established melanoma.Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells.Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
P2860
Q26778833-463A70FB-F2DF-4108-9274-04FA295BD131Q26825418-3FA2CA00-EB16-46A6-9B16-A37AE07DD4EAQ27027078-D4A41737-770F-42A3-B7DF-C144EEFC5AA8Q28385606-6779A9E4-3640-42D0-A1F1-3087F7E196FEQ28386699-DFBB7CFE-F08C-40C9-9082-E3BEE367F7A7Q34506877-4411F9D6-20D9-490C-9AC8-277AAA169B75Q35067368-FABD2B19-8CA5-42FB-BD21-48410E7B0EB1Q35740218-6242FA38-7C0B-4694-81C4-BD322487AA1EQ35967474-3C06FFAC-2FFA-4477-A530-4C7033B3AF86Q36372698-8215600A-BF09-4A54-9185-7B5458C17D76Q36452648-205128AF-2362-4D52-B626-6EF0A348D2FEQ36756695-3E75CBDA-BCC0-46DA-83E4-EFE6553376A0Q36822999-7975727F-8557-44F3-8F33-09A09C571918Q36884768-5AE38A83-AB74-4419-A64D-B1A3B83A792AQ37031671-88611085-801C-4F31-9EEE-A7D8A0FFD863Q37318674-BCCA0E84-0A41-48A9-9788-D2965E6AC80CQ37367163-EB21FEF2-73B9-464C-B256-B1214BE937CBQ37465136-759F5C0E-4114-43B9-8E27-D0CD767A4B83Q37591932-04B5EDED-DAFB-48C5-AE10-A0D288FC3C8AQ37906630-090B817C-4690-465E-A2BF-87EE254FCA5CQ38165210-B792618F-BBB6-4B1B-A725-E49760F327C9Q38354723-460A2F83-63A6-4B36-9595-DC3F3CF92316Q38461061-4669050B-8A4F-4F9E-B815-4E9358B89D07Q38607376-1A8F4B7A-64D3-46D5-88E6-40CA6074184FQ38665350-14B3AE73-B810-4E88-9436-62E495D571E9Q38838467-A189A80C-64B8-4F01-A109-FB6F8E904D31Q38961842-78F30544-6368-481B-B3D5-E7E6D33E6F6EQ39179977-049130BF-E06F-4272-B186-A7837FC1F662Q39462920-86F22BB3-2E5D-4F26-A128-6A39A8E3DEB3Q39985946-2A24C597-B1CB-4371-A1B4-08F4570F8C98Q43165459-A14E6012-AE67-43B3-BE81-1D09826C5557Q47318857-4C79B0E1-01FB-413A-A968-D983E72D4D22Q47375550-2410AE11-DC3E-4F73-8ABD-7D5D83E518DAQ47730028-3D6F9266-E2EF-436B-B594-F04C0DB818DBQ48147751-A82C3029-EE93-41E2-8BE6-4AAB816E1DB0Q48162156-1FDA06E7-2FC2-4875-90ED-FF48AB540BC5Q49391681-57F727DB-540B-4871-AABA-541A0B136EB9Q52848957-4F4B511E-2898-44B7-BE01-E2397DDE52FAQ53275631-6333FDA2-510C-47EA-ADCD-DD3197BF3A23Q57492118-08FA6087-66AA-46D0-8E00-9BBB660A1C22
P2860
Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanotechnology-based manipulat ...... nced immunotherapy strategies.
@en
Nanotechnology-based manipulat ...... nced immunotherapy strategies.
@nl
type
label
Nanotechnology-based manipulat ...... nced immunotherapy strategies.
@en
Nanotechnology-based manipulat ...... nced immunotherapy strategies.
@nl
prefLabel
Nanotechnology-based manipulat ...... nced immunotherapy strategies.
@en
Nanotechnology-based manipulat ...... nced immunotherapy strategies.
@nl
P1476
Nanotechnology-based manipulat ...... nced immunotherapy strategies.
@en
P2093
David Pozo
Rebecca Klippstein
P304
P356
10.1016/J.NANO.2010.01.001
P577
2010-01-18T00:00:00Z